The trademark application HEMGENIX was filed by CSL Behring L.L.C., a Limited Liability Company (the "Applicant"). The application was published for oppositions on September 21, 2021, and it was registered by office on December 29, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).